Community Bank’s Fate Therapeutics FATE Stock Holding History

Community Bank’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,500	Closed	-$24K	–	499
2018 Q3	$24K	Hold	1,500	–	–	﹤0.01%	335
2018 Q2	$17K	Hold	1,500	–	–	﹤0.01%	360
2018 Q1	$15K	Sell	1,500 -3,000	-67%	-$28.7K	﹤0.01%	380
2017 Q4	$27K	Sell	4,500 -4,000	-47%	-$17.8K	﹤0.01%	424
2017 Q3	$34K	Buy	8,500 +2,000	+31%	+$6.8K	﹤0.01%	381
2017 Q2	$21K	Hold	6,500	–	–	﹤0.01%	404
2017 Q1	$30K	Buy	+6,500	New	+$23.8K	0.01%	276

Other funds holding FATE

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Community Bank's FATE Position: Q4 2018 in Review

Community Bank sold out of Fate Therapeutics (FATE) in Q4 2018, closing a stake of 1,500 shares — an estimated $24K sold.

Community Bank first reported a position in FATE in Q1 2017 and held it in 7 quarters. The position peaked at $34K in Q3 2017. 122 funds tracked by Wall St. Rank hold FATE as of Q4 2018.

Community Bank reported no remaining Fate Therapeutics position as of Q4 2018 after selling out during the quarter.
Community Bank sold 1,500 Fate Therapeutics shares in Q4 2018, an estimated $24K.
Community Bank first reported a position in Fate Therapeutics in Q1 2017 and held it in 7 quarters.
Community Bank's Fate Therapeutics position peaked at $34K in Q3 2017.
122 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2018.

Based on Community Bank's 13F filing for Q4 2018, filed 30 Jan 2019.